Control group:Placebo 10ml / time, 2 times a day

2 trials

Sponsors

Wuhan Third Hospital

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Phase 4

A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient

RecruitingITMCTR2000003304

Wuhan Third HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-05-08Updated: 2023-02-20

A multicenter, randomized, double-blind, placebo-controlled trial for Lu-Dang-Shen oral liquid in the treatment of reduced digestion function of convalescent new coronavirus pneumonia (COVID-19) patient

RecruitingChiCTR2000032919

Wuhan Third HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2020-05-08Updated: 2020-05-18